Latest Conference

Vincenzo Di Nicola has won the Award for Leadership in Child, Adolescent, and Young Adult Psychiatry. Learn more about his thoughts on trauma, leadership, and issues in child and adolescent psychiatry.

Catch up on coverage from the 30th Annual Nevada Psychiatric Association National Psychopharmacology Update.

A 52-week study presented at the 30th Annual Nevada Psychiatric Association National Psychopharmacology Update offered a promising new approach to schizophrenia treatment.

A 52-week study presented at the 30th Annual Nevada Psychiatric Association National Psychopharmacology Update offered a promising new approach to schizophrenia treatment.

Learn more about the findings from the first 3 EMERGENT trials, and their use in the 4th and 5th trials, presented at the 30th Annual Nevada Psychiatric Association National Psychopharmacology Update.

A pooled analysis of two clinical trials highlights AXS-05’s rapid and sustained effectiveness in reducing depressive symptoms, offering a promising new treatment option for major depressive disorder with a manageable safety profile.

A new phase 2 trial reveals a novel antidepressant delivers rapid symptom relief for major depressive disorder, with patients experiencing significant improvement within just hours of their first dose.

Check out some of the top clinical pearls gleaned from presenters at Real Psychiatry.

Check out 2 high-level examples of patient quality of life improvement following treatment for tardive dyskinesia.

What are the signs of increased struggle with tardive dyskinesia? Here's what Erin Crown, MHS, PA-C, Psych-CAQ, picks up on during patient visits.

Tardive dyskinesia can be difficult to discern...

Here's how to address medication side effects with patients.

COVID-19 increased the usage of telemedicine drastically, but is that always a good thing?

What 5 factors should you look at when selecting ADHD treatment?

Let's explore COVID-19's impact on psychiatric research...

Let's define success for patients with ADHD...

"Who are you important to? If you passed tomorrow, who would show up at your funeral?"

When a patient has comorbidities like anxiety, substance use, and depression, how can you best select a treatment?

Come celebrate the evolution of Psychiatric Times and psychiatry as a whole!

When prescribing ADHD medications, when is the best time to switch treatments?

How can we improve patient outcomes? Collaboration.

Ancillary symptoms may be key in guiding treatment management for ADHD.

Here are 4 things to do when implementing a treatment strategy for tardive dyskinesia.

Comorbid bipolar disorder and ADHD: a big problem.

Here's how to have productive conversations with patients with tardive dyskinesia in order to improve outcomes.

How can we get back to recovery as the treatment goal for schizophrenia?

2024 into 2025: a period of highs and lows for schizophrenia treatment.

We're excited to preview our new upcoming partnership with the Psych NP Network at Real Psychiatry!

How has bipolar treatment changed over the past 40 years? The celebration of 40 years of Psychiatric Times continues at the Real Psychiatry conference.

Check out these top tips for treating postpartum depression from the Real Psychiatry conference!